3 recruiting, 1 not yet recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow CIDP: new trials by email Literature Review of CIDP trials Research Report on CIDP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Empasiprubart IV - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) | Phase 2 / Phase 3 | Not yet recruiting | argenx | 6 | 2026-09-01 | 2026-06-10 |
| A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP Empasiprubart IV, Placebo IV - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 160 | 2025-09-16 | 2026-11-09 |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP empasiprubart, IVIg, empasiprubart-placebo - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 218 | 2025-08-22 | 2026-11-03 |
| Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Rituximab (Mabthera) - CIDP | Phase 3 | Recruiting | Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) | 100 | 2024-10-16 | 2024-12-04 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (4)
Autoimmune Diseases (4) · Autoimmune Diseases of the Nervous System (4) · Chronic Disease (4) · Demyelinating Diseases (4) · Disease Attributes (4) · Immune System Diseases (4) · Nervous System Diseases (4) · Neuromuscular Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Peripheral Nervous System Diseases (4) · Polyneuropathies (4) · Polyradiculoneuropathy (4)
Immunoglobulins, Intravenous (1) · Rituximab (1)
argenx (3) · Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) (1)
Netherlands (3) · Argentina (2) · Austria (2) · Brazil (2) · Colombia (2) · Czechia (2) · Estonia (2) · France (2) · Greece (2) · Hungary (2) · Israel (2) · Italy (2) · Japan (2) · Poland (2) · Romania (2)
2025 (2)